-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Positron Emitting Tomography Contrast Agents · Magnetic Resonance Imaging (MRI) Contrast Agents · Gadolinium-based MRI Contrast Agents...
-
Product Insights
Bone Grafts and Substitutes Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Bone Grafts and Substitutes Pipeline Market Report Overview Bone grafts and substitutes are used in surgical procedures of bones in the human body. It is used in two cases either when there is a breakage in the bone or in the case of a void between or in the bones due to several factors such as age and degenerative diseases. Bone graft substitutes are synthetic substances that are an alternative to bone allografts and autografts. Allograft Bone Chips, Bone Morphogenetic...
-
Product Insights
NewPrecision Molecular Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Precision Molecular Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Precision Molecular Inc (Precision Molecular) is engaged in developing imaging biomarkers and theragnostic. Precision Molecular is headquartered in Gaithersburg, Maryland, the US. GlobalData's Medical Devices company profile report, “Precision Molecular Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related...
-
Product Insights
Microvascular Therapeutics LLC Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Microvascular Therapeutics LLC Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Microvascular Therapeutics LLC (MVT) is a biotechnology company which has developed a new, improved, patented, ultrasound contrast agent via the MVT-100. The company has products for molecular imaging and theragnostic for cancer and heart disease. MVT is headquartered in Tucson, Arizona, the US. GlobalData's Medical Devices company profile report, “Microvascular Therapeutics LLC Pipeline Insight and Competitive Landscape, 2023" provides...
-
Sector Analysis
Orthobiologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. The orthobiologics category covers bone graft substitutes, bone growth stimulators, cartilage repair and viscosupplementation products. The orthobiologics pipeline market research report provides comprehensive information about the orthobiologics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Burns Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
A Burn is damage to body's tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include pain, increasing with each degree of burn, red and swollen skin, blisters and charred and blackened skin. Treatment includes antibiotics and pain relievers. The Burn - Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Burn, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The...
-
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...